Navigation Links
Shimadzu Introduces New Particle Size Analyzer for Measurement of Nanoparticles in Life Sciences and R&D
Date:1/6/2014

Columbia, MD (PRWEB) January 06, 2014

Shimadzu Scientific Instruments Inc. has introduced the SALD-7500nano, a highly sensitive particle size analyzer that can accurately measure nanoparticles in low concentrations or those that demonstrate high light absorption. The analyzer also provides real-time tracing of changes across a wide range of particle sizes.

The SALD-7500nano analyzer offers significantly improved sensitivity for the analysis of nanoparticles. The system is capable of a wide measurement range, from primary particles to sub-visible particles (SVP) and contaminants, and allows measurements across a broad concentration range from 0.01 ppm to 20 percent. It enables measurement of micro bubbles from 100 nm to 60 µm and real-time tracking of changes in bubble diameter.

The SALD-7500nano features a single light source and wide-angle detection method, allowing high-speed measurement to a minimum of 1 second and real-time display of particle size distribution at 1-second intervals. Functions for statistical processing and 3D display of the particle reaction processes offer multifaceted analyses and evaluations.

The system uses an omnidirectional shock absorption frame (OSAF) to improve instrument stability and provide high reproducibility, while built-in self-diagnostic functions ensure easy maintenance. A number of data analysis functions, including data emulation and mixture data simulation, provide for more efficient data processing.

When used with Shimadzu’s new Aggregates Sizer Aggregation Analysis System, the analyzer enables measurement and analysis of SVP in biopharmaceuticals and can evaluate SVP concentrations that can induce allergic reactions and other severe side effects.

For more information, visit http://www.ssi.shimadzu.com/products/product.cfm?product=sald-7500nano.

About Shimadzu Scientific Instruments Inc.
Shimadzu Scientific Instruments (SSI) is the American subsidiary of Shimadzu Corp., headquartered in Kyoto, Japan. Founded in 1875, Shimadzu is a $3 billion multinational corporation with three major divisions: Medical Diagnostics, Aerospace/Industrial and Analytical Instruments. In the United States, SSI has a network of more than 50 locations providing local and regional sales, service and technical support.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11464795.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Shimadzu's New DSC-60 Plus Series Differential Scanning Calorimeters Offer High-Sensitivity Analysis in Polymer, Food and Pharmaceutical Applications
2. Shimadzu's New MALDI-7090 TOF-TOF Mass Spectrometer Combines High Throughput, High Resolution and High Energy for the Ultimate in Tandem MS Capabilities
3. Shimadzu's New HMV-G Series Hardness Testers Ensure Reliable, High-Quality Testing With Automatic Length Measurement
4. Shimadzu’s New Triple Quadrupole LCMS-8050 Mass Spectrometer Offers Combination of Outstanding Sensitivity With Ultra-fast, Accurate Analysis
5. Shimadzu’s New Aggregates Sizer Aggregation Analysis System for Biopharmaceuticals Enables Real-time Quantitative Analysis
6. New England Biolabs Introduces Polbase, an Information Repository of Scientific Data for Polymerase Researchers
7. PAREXEL Introduces Executive Briefing Series on Proven Practices to Assist Emerging and Mid-size Biopharma in Achieving Better Outcomes
8. Leading Pharmaceutical Marketing Research and Consulting Company Introduces Intelligent Efficiency Program
9. NextGen introduces its first generation of animal biomarker products for development of brain disorder diagnostics
10. WHEATON® Introduces a New Web Community for Scientists, Researchers, and Biopharmaceutical Packagers
11. Profit Lifter for Pro Mold Removers: Molderizer Introduces Remediation Product Like No Other
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)...  Bayer today announced that a Phase III ... (regorafenib) tablets for the treatment of patients with ... endpoint of a statistically significant improvement in overall ... and safety of regorafenib in patients with HCC ... The safety and tolerability were generally consistent with ...
(Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... recent innovations in biotechnology to help treat hormonal and stress related hair loss. ... has captured the hearts of key opinion leaders in the medical and salon ...
(Date:5/3/2016)... , ... May 03, 2016 , ... ... at Boston CEO 2016 on May 31st and June 1st at The Four ... for leading executives in the life sciences, offering exclusive access to key decision ...
(Date:5/3/2016)... 2016 - And Other Rising ... of Those Competitor Biologics  - Biosimilar Drug ... Prospects ,  Who are the most important ... are their sales potentials? Discover, in our updated survey, ... opportunities and revenue forecasting. Visiongain,s ...
Breaking Biology Technology:
(Date:4/26/2016)... DUBLIN , April 27, 2016 ... of the  "Global Multi-modal Biometrics Market 2016-2020"  report ... ) , The analysts forecast ... a CAGR of 15.49% during the period 2016-2020.  ... a number of sectors such as the healthcare, ...
(Date:4/14/2016)... 2016 BioCatch ™, the ... announced the appointment of Eyal Goldwerger as ... Goldwerger,s leadership appointment comes at a time of ... deployment of its platform at several of the world,s ... discerns unique cognitive and physiological factors, is a winner ...
(Date:3/29/2016)... , March 29, 2016 ... "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect are pleased to ... ink used in a variety of writing instruments, ensuring ... of originally created collectibles from athletes on LegacyXChange will ... analysis of the DNA. Bill Bollander ...
Breaking Biology News(10 mins):